ANKHD1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 8.05369999579142E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.564790E-04 |
Normal-vs-Stage2 |
1.989010E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.041800E-02 |
Stage1-vs-Stage2 |
6.249000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.329800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.560400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.15060000005496E-06 |
Normal-vs-AfricanAmerican |
5.07560000029272E-07 |
Normal-vs-Asian |
1.143410E-01 |
Caucasian-vs-AfricanAmerican |
2.011800E-02 |
Caucasian-vs-Asian |
6.639000E-01 |
AfricanAmerican-vs-Asian |
1.139640E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.826100E-04 |
Normal-vs-Female |
1.50590999999922E-05 |
Male-vs-Female |
1.944970E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.235600E-02 |
Normal-vs-Extreme_Weight |
1.62857999999044E-05 |
Normal-vs-Obese |
7.242300E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.082000E-01 |
Normal_Weight-vs-Obese |
5.419400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.148400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.69659999999161E-06 |
Normal-vs-Age(41-60Yrs) |
3.639200E-03 |
Normal-vs-Age(61-80Yrs) |
6.33300000000281E-05 |
Normal-vs-Age(81-100Yrs) |
2.917000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.057600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.484410E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.618800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.947800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.627000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.045600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.546600E-01 |
Normal-vs-Grade 3 |
6.923400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.410800E-01 |
Grade 2-vs-Grade 4 |
5.546600E-01 |
Grade 3-vs-Grade 4 |
6.923400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.76839999999068E-06 |
Normal-vs-N1 |
5.90879999999849E-05 |
N0-vs-N1 |
9.431000E-01 |
|
|